Departments of Pulmonary Diseases of Catharina Hospital Eindhoven; St Anna Hospital Geldrop; VU University Medical Center Amsterdam; Department of Radiology; Department of Nuclear Medicine, Catharina Hospital Eindhoven; Department of Thoracic Surgery of Catharina Hospital Eindhoven, the Netherlands.
J Oncol Pract. 2007 Sep;3(5):242-7. doi: 10.1200/JOP.0752002.
In this study, we investigated the impact of implementation of [(18)F] fluorodeoxyglucose positron emission tomography (FDG-PET) in daily practice on adherence to mediastinal staging protocols and performance of mediastinoscopy in non-small-cell lung cancer (NSCLC) patients who are possible candidates for surgical resection. Institutional review board approval was obtained.
From a nonuniversity teaching hospital and three surrounding community hospitals in Eindhoven, the Netherlands, we studied data from 143 patients with NSCLC who underwent mediastinoscopy and/or thoracotomy in three consecutive periods (1, 0 to 9 months; 2, 10 to 18 months; and 3, 19 to 31 months) after introduction of PET. Mediastinoscopy was indicated in case of enlarged and/or PET-positive nodes. Adherence to these surgical mediastinal staging guidelines and the performance of PET and mediastinoscopy were investigated and compared between the three periods and with our previous study before introduction of PET.
Guidelines for indicating mediastinoscopy were adequately followed in significantly more instances after introduction of PET (80%), compared with the period before PET (66%). Optimal yield (lymph node stations 4, right and left, and 7) of mediastinoscopy (in 27% of patients) was not significantly different from the period before PET (39% of patients). Compared with the historical data, the percentage of positive mediastinoscopies increased from 15.5 to 17.6 (not significant). We found no significant differences between the three consecutive periods with regard to adequacy of indicating and performance of mediastinoscopy. After introduction of PET, adherence to staging guidelines with respect to mediastinoscopy improved. Although fewer mediastinoscopies had an optimal yield, more proved to be positive for metastases. Nevertheless, when a mediastinoscopy is indicated, surgeons must be encouraged to reach an optimal yield because PET positive nodes might be false negative. This occurred in 5% to 6% of all patients.
本研究旨在探讨氟-18 脱氧葡萄糖正电子发射断层扫描(FDG-PET)在日常实践中的应用对纵隔分期方案的遵循情况和非小细胞肺癌(NSCLC)患者行纵隔镜检查的影响,这些患者可能是手术切除的候选者。本研究获得了机构审查委员会的批准。
从荷兰埃因霍温的一家非大学教学医院和三家周边社区医院中,我们研究了连续三个时期(1,引入 PET 后 0 至 9 个月;2,引入 PET 后 10 至 18 个月;3,引入 PET 后 19 至 31 个月)内行纵隔镜检查和/或开胸术的 143 例 NSCLC 患者的数据。如果存在淋巴结肿大和/或 PET 阳性,即指示行纵隔镜检查。我们研究并比较了三个时期以及引入 PET 之前的我们之前的研究中,这些外科纵隔分期指南的遵循情况以及 PET 和纵隔镜检查的执行情况。
与引入 PET 之前的时期(66%)相比,引入 PET 后,纵隔镜检查的指示明显更符合指南(80%)。纵隔镜检查的最佳(右、左和 4 淋巴结站和 7 淋巴结站)检出率(27%的患者)与引入 PET 之前的时期(39%的患者)相比无显著差异。与历史数据相比,阳性纵隔镜检查的比例从 15.5%增加到 17.6%(无显著差异)。在连续三个时期内,纵隔镜检查的指示和执行情况之间没有显著差异。引入 PET 后,纵隔镜检查的分期指南遵循情况有所改善。尽管最佳检出率较低,但更多的纵隔镜检查被证实存在转移。然而,当指示行纵隔镜检查时,必须鼓励外科医生达到最佳检出率,因为 PET 阳性的淋巴结可能是假阴性的。这种情况发生在所有患者的 5%-6%。